IP Library Patent Application 16165100
Patent Application
App. No. 16/165,100

OMEGA-3 COMPOSITIONS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/165,100
Abstract

The present invention relates to compositions comprising omega-3 fatty acid derivatives, and in particular to compositions comprising omega-3 phospholipids in combination with other omega-3 derivatives.

Claims (39)

1 . A composition comprising a mixture of phospholipid compounds having the following structure:

wherein R1 and R2 are selected from the group consisting of a fatty acid moiety and H and R3 is H or a choline, ethanolamine, inositol and serine moiety, said mixture of phospholipid compounds comprising more than about 90% choline moieties at position R3 and more than about 30% w/w omega-3 fatty acid moieties, wherein more than about 90% w/w of said omega-3 fatty acid moieties are at position R2,

and

a mixture of omega-3 fatty acid derivatives selected from the group consisting of:

a mixture of glyceride compounds having the following structure:

wherein at least one of either R1, R2, and R3 is a an omega-3 fatty acid moiety, and the other two of either R1, R2 and R3 may H or a fatty acid moiety, and

esters and free fatty acids of omega-3 fatty acids, and combinations thereof.

2 . The composition of claim 1 , wherein said mixture of omega-3 fatty acid derivatives comprises at least 30% omega-3 fatty acid moieties on a w/w basis.

3 . The composition of claim 1 , wherein said mixture of omega-3 fatty acid derivatives comprises at least 50% omega-3 fatty acid moieties on a w/w basis.

4 . The composition of claim 1 , wherein said mixture of omega-3 fatty acid derivatives comprises at least 65% omega-3 fatty acid moieties on a w/w basis.

5 . The composition of claim 1 , wherein said composition comprises at least 80% omega-3 fatty acid moieties on a w/w basis.

6 . The composition of claim 1 , wherein said omega-3 fatty acid moieties are selected from the group consisting of eicosapentaenoic acid, docosahexaenoic acid, and combinations thereof.

7 . The composition of claim 1 , wherein said composition comprises at least 5% w/w of said phospholipid compounds.

8 . The composition of claim 1 , wherein said composition comprises at least 25% w/w of said phospholipid compounds.

9 . The composition of claim 1 , wherein said composition comprises at least 50% w/w of said phospholipid compounds.

10 . The composition of claim 1 , wherein said composition comprises at least 70% w/w of said phospholipid compounds.

11 . The composition of claim 7 , wherein said omega-3 moieties in said mixture of mixture of phospholipid compounds are eicosapentaenoic acid and said docosahexaenoic acid and wherein said eicosapentaenoic acid and said docosahexaenoic acid are present in a ratio of eicosapentaenoic acid:docosahexaenoic acid of from about 1:1 to about 3:1.

12 . The composition of claim 7 , wherein said composition comprises at least 10% ethyl esters comprising said omega-3 fatty acid moieties.

13 . The composition of claim 7 , wherein said composition comprises at least 20% ethyl esters comprising said omega-3 fatty acid moieties.

14 . The composition of claim 7 , wherein said composition comprises at least 30% ethyl esters comprising said omega-3 fatty acid moieties.

15 . The composition of claim 7 , wherein said composition comprises at least 50% ethyl esters comprising said omega-3 fatty acid moieties.

16 . The composition of claim 7 , wherein said composition comprises at least 70% ethyl esters comprising said omega-3 fatty acid moieties.

17 . The composition of claim 7 , wherein said composition comprises at least 90% ethyl esters comprising said omega-3 fatty acid moieties.

18 . The composition of claim 7 , wherein said composition comprises at least 10% glyceride compounds comprising said omega-3 fatty acid moieties.

19 . The composition of claim 7 , wherein said composition comprises at least 30% glyceride compounds comprising said omega-3 fatty acid moieties.

20 . The composition of claim 7 , wherein said composition comprises at least 50% glyceride compounds comprising said omega-3 fatty acid moieties.

21 . The composition of claim 7 , wherein said composition comprises at least 70% glyceride compounds comprising said omega-3 fatty acid moieties.

22 . The composition of claim 7 , wherein said composition comprises at least 90% glyceride compounds comprising said omega-3 fatty acid moieties.

23 . The composition of any of claim 7 , wherein said composition comprises at least 10% omega-3 free fatty acids.

24 . The composition of claim 7 , wherein said composition comprises at least 30% omega-3 free fatty acids.

25 . The composition of claim 7 , wherein said composition comprises at least 50% omega-3 free fatty acids.

26 . The composition of claim 7 , wherein said composition comprises at least 70% omega-3 free fatty acids.

27 . The composition of claim 7 , wherein said composition comprises at least 90% omega-3 free fatty acids.

28 . The composition of claim 7 , wherein said omega-3 fatty acid moieties or free fatty acids are selected from the group consisting of eicosapentaenoic acid and docosahexaenoic acid and combinations thereof.

29 . The composition of claim 28 , wherein said eicosapentaenoic acid and said docosahexaenoic acid are present in a ratio of eicosapentaenoic acid:docosahexaenoic acid of from about 1:1 to about 3:1.

30 . The composition of claim 1 , wherein said composition comprises astaxanthin.

31 . The composition of claim 1 , wherein said composition comprises at least a second antioxidant.

32 . The composition of claim 1 , wherein said composition is partially or totally derived from krill.

33 . The composition of claim 1 , wherein said composition is provided in a formulation selected from the group consisting of a capsule, a tablet, a liquid, a powder, an emulsion, a dietary supplement, a nutritional supplement, a beverage and a functional food.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2018
From: HOEM, NILS; BURRI, LENA; BERGE, KJETIL
To: AKER BIOMARINE ANTARCTIC AS
Reel/Frame 047521/0430 →